Klinge Ladefoged (plantevent2)
In today's routine practice, the task of recognizing patients who are not adhering to their prescribed therapies poses a problem where an ideal solution is not yet established. The presence of certain clinical red flags compels the clinician to investigate the possibility of non-adherence. The most effective approach to date for assessing chemical adherence is via serum or urine antihypertensive levels, which should be employed whenever possible. For an alternative, examining prescription refills within the patient's electronic medical records, or utilizing direct-observed therapy with subsequent ambulatory blood pressure monitoring, can be considered. We offer a simple algorithm designed to assist clinicians in recognizing non-adherence in their work. Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici (Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luis Bronze (Portugal), John Chalmers (Australia), Tine De Backer (Belgium), Alejandro de la Sierra (Spain), Kyriakos Dimitriadis (Greece), Dorota Drożdż (Poland), Beatrice Duly-Bouhanick (France), Brent M. Egan (USA), Serap Erdine (Turkey), Claudio Ferri (Italy), Anthony Heagerty (UK), Slavomira Filipová (Slovak Republic), Michael Hecht Olsen (Denmark), Dagmara Hering (Poland), Uday Jadhav (India), Manolis Kallistratos (Greece), Kazuomi Kario (Japan), Vasilios Kotsis (Greece), Adi Leiba (Israel), Patricio López-Jaramillo (Colombia), Hans-Peter Marti (Norway), Terry McCormack (UK), Paolo Mulatero (Italy), towards B. Ozzi (Nigeria), Sungha Park (South Korea), Priit Pauklin (Estonia), Sabine Perl (Austria), Arman Postadzhian (Bulgaria), Aleksander Prejbisz (Poland), Venkata Rama (India), Ramiro Sánchez (Argentina), Markus Schlaich (Australia), Alta Schutte (Australia), entinostat inhibitor Cristina Sierra (Spain), Sekib Sokolovic (Bosnia and Herzegovina), Jonas Spaak (Sweden), Dimitrios Terentes-Printzios (Greece), Bruno Trimarco (Italy), Thomas Unger (The Netherlands), Bert-Jan van den Born (The Netherlands), Anna Vachulova (Slovak Republic), Agostino Virdis (Italy), Jiguang Wang (China), Ulrich Wenzel (Germany), Paul Whelton (USA), Jiri Widimsky (Czech Republic), Jacek Wolf (Poland), Gregoire Wuerzner (Switzerland), Eugene Yang (USA), Yuqing Zhang (China). Data collected from multiple perspectives on the identical set of samples (multi-view data) has been instrumental in driving significant progress in the field of data integration, leveraging low-rank matrix factorization methods. These methods decompose the signal matrices from every perspective into their shared and individual components, subsequently enabling techniques for dimensionality reduction, exploratory research, and the evaluation of connections between the diverse perspectives. While existing methods exist, they are hampered in modeling partially-shared structures due to either the restrictive nature of the models themselves or the strict requirements for identifiability. To confront these problems, we propose a new signal format for signal structures, which incorporates partially shared signals through the organization of viewpoints into identifiable hierarchical levels, offering guarantees under specific conditions. Given the hierarchical framework, we propose introducing the hierarchical nuclear norm (HNN) penalty to enhance signal estimation. Departing from existing methods, HNN penalization steers clear of the factorization of signal scores and loadings, resulting in a convex optimization problem that we solve via a dual forward-backward algorithm. We introduce a simple refitting process to mitigate penalization bias, and a customized bi-cross-validation strategy for selecting tuning parameters. Through extensive simulation studies and a meticulous analysis of genotype-tissue expression data, our method showcases its superior performance over existing alternatives. We sought to pinpoint intergenerational solidarity (emotional closeness, in-person contac
